Axonyx Inc.
750 Lexington Avenue
Suite 1400
New York
New York
10022
United States
Tel: 212-688-4770
Fax: 212-688-4843
Website: http://www.axonyx.com/
Email: info@axonyx.com
23 articles about Axonyx Inc.
-
TorreyPines Therapeutics, Inc. Completes Merger With Axonyx Inc.
10/4/2006
-
Axonyx Inc. Stockholders Approve Merger With TorreyPines Therapeutics, Inc.
9/29/2006
-
Axonyx Inc. Announces Second Quarter 2006 Financial Results
8/8/2006
-
Axonyx Inc. Receives Notice Related To Nasdaq Minimum Bid Price Rule
8/7/2006
-
The Day In Review: FDA Approves Merck & Co., Inc.’s Gardasil
6/8/2006
-
Axonyx Inc. And TorreyPines Therapeutics, Inc. To Host Webcast And Conference Call On Announced Merger
6/8/2006
-
Axonyx Inc. And TorreyPines Therapeutics, Inc. Announce Merger Agreement
6/8/2006
-
Axonyx Inc. Reports First Quarter 2006 Financial Results
5/11/2006
-
Axonyx Inc. To Present At The Rodman & Renshaw 3rd Annual Global Healthcare Conference
5/9/2006
-
Axonyx Inc. Reports Data On Effects Of Phenserine On The Brains Of Alzheimer's Disease Patients
4/21/2006
-
Axonyx Inc. Reports Fourth Quarter And Full Year 2005 Financial Results
3/17/2006
-
Axonyx Inc. Regains Compliance With Nasdaq Minimum Bid Price Rule
3/9/2006
-
Axonyx Inc. To Present At The Wall Street Analyst Forum
2/23/2006
-
Axonyx Inc. Reports Phenserine Associated With Significant Amyloid Reduction In Phase I Trial
2/14/2006
-
Axonyx Inc. To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference 2006
2/7/2006
-
Axonyx Inc. Announces Acceptance Of Four Abstracts Highlighting Phenserine And Posiphen By The 9th International Geneva/Springfield Symposium On Advances In Alzheimer Therapy
1/31/2006
-
Axonyx Inc. Completes First Phase I Trial With Posiphen For Alzheimer's Disease Progression
1/24/2006
-
Axonyx Inc. Announces License Of Phenserine To Daewoong Pharmaceutical Co., Ltd. For South Korea
1/4/2006
-
Axonyx Inc. Receives Notice Related To Nasdaq Minimum Bid Price Rule
12/22/2005
-
Axonyx Inc. Reports Statistically Significant Result For Phenserine In Alzheimer's Disease; Additional Analysis Results From Curtailed Phase III Clinical Trials
11/29/2005